Earlier this summer, I concluded to keep an eye on shares of STAAR Surgical (NASDAQ:STAA). The manufacturer of the so-called EVO ICL Lens, a clear vision solution for nearsightedness which does ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...

EMEA Up 12% and APAC Up 9% Market Building Initiatives Drive EVO ICL™ Uptake and Reinforce Opportunity STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of ...

8 undervalued tech stocks offer attractive prices in a predominantly overvalued sector. We sell different types of products and services to both investment professionals and individual investors ...

Staar Surgical Company ( (STAA)) has realeased its Q3 earnings. Here is a breakdown of the information Staar Surgical Company presented to its investors. STAAR Surgical Company is a prominent ...

LONDON, Nov. 4, 2024 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer, and marketer of the EVO family of Implantable Collamer ® lenses (EVO ICL™) for ...

--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and ...

November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and ...

The live webcast link includes an option to pre-register. An online replay of the webcast will also be available on STAAR’s investor website at https://investors ...